EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Focused Power Ultrasound Mediated Inferior Perirenal Adipose Tissue Modification Therapy for Essential Hypertension: A Pilot Study

Yang Hua, Meng-Huan Li, Ting-Ting Wu, Lei Jing, Ming Jiang, Cui-Ying Liu, Jia-Ming Yang, Yu-Xuan Lou, Yue Yuan, Yun-Fan Tian, Min Zhang, Rong-Sheng Wang und 4 weitere

The Journal of Clinical Hypertension · 2025

DOI: 10.1111/jch.70166 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Clinical Hypertension, 2025. Verfasst von Yang Hua und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China. Hauptthemen laut MEDLINE: Essential Hypertension, Adipose Tissue, Hypertension, Ultrasonic Therapy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: the National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Perirenal adipose tissue (PRAT) contributes to the maintenance of elevated blood pressure through afferent nerves and serves as an important peripheral, modifiable target for hypertension management. This single‐center, prospective pilot trial assessed the feasibility and safety of a novel focused power ultrasound device for perirenal adipose tissue modification (PRATM) therapy in essential hypertension. Twenty patients (mean age 47.5 ± 11.0 years, 85% male) with office systolic blood pressure (OSBP) 140–180 mmHg or diastolic blood pressure (ODBP) ≥90 mmHg were enrolled. All underwent PRATM therapy and were followed for 3 months. The primary endpoint was all‐cause mortality or device‐related adverse events (AEs). Four patients experienced transient mild lumbar pain, and one had mild skin redness, all resolving spontaneously. No serious AEs or clinically significant abnormalities were observed. OSBP decreased by 14.6 mmHg at 1 month and 18.2 mmHg at 3 months; ODBP decreased by 5.8 mmHg and 2.8 mmHg, respectively. For the 24‐hour ambulatory blood pressure monitoring (ABPM), 24‐hour ambulatory SBP decreased by 3.6 mmHg (95% CI: ‐3.6‐10.8 mmHg) and 24‐hour ambulatory DBP decreased by 2.2 mmHg (95% CI: −2.7–7.0 mmHg) at 1 month. At 3 months, 24‐hour ambulatory SBP decreased by 2.8 mmHg (95% CI: −5.4–11.0 mmHg) and 24‐hour ambulatory DBP decreased by 1.7 mmHg (95% CI: −4.0‐7.3 mmHg). PRATM shows preliminary feasibility and safety, but larger, randomized trials are needed for definitive efficacy and long‐term safety validation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Essential HypertensionAdipose TissueHypertensionUltrasonic TherapyHumansMalePilot ProjectsMiddle AgedFemaleProspective StudiesAdultBlood Pressure Monitoring, AmbulatoryBlood PressureTreatment OutcomeFeasibility Studies

Stichwörter der Autor:innen

essential hypertensionfeasibilityfocused power ultrasound (FPU)perirenal adipose tissue modification (PRATM)safety

Autor:innen und Institutionen

  • Department of Cardiology, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China.
  • Department of Cardiology, The First Affiliated Hospital with Nanchang University, Nanchang, China.
  • Department of Ultrasound, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China.
  • Department of Cardiology, The Affiliated Suzhou Hospital with Nanjing Medical University, Suzhou Municipal Hospital, Gusu School, Nanjing Medical University, Suzhou, China.
  • Department of Oncology, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China.
  • Nanjing Khons Medtech Co., Ltd, Nanjing, China.

Förderung

  • the National Key Research and Development Program of China

Zitieren

APA

Hua, Y., Li, M. H., Wu, T. T., Jing, L., Jiang, M., Liu, C. Y., Yang, J. M., Lou, Y. X., Yuan, Y., Tian, Y. F., Zhang, M., Wang, R. S., Cai, J., Sheng, Y. H., Sun, W., & Kong, X. Q. (2025). Focused Power Ultrasound Mediated Inferior Perirenal Adipose Tissue Modification Therapy for Essential Hypertension: A Pilot Study. The Journal of Clinical Hypertension. https://doi.org/10.1111/jch.70166

Vancouver

Hua Y, Li MH, Wu TT, Jing L, Jiang M, Liu CY, et al. Focused Power Ultrasound Mediated Inferior Perirenal Adipose Tissue Modification Therapy for Essential Hypertension: A Pilot Study. The Journal of Clinical Hypertension. 2025. doi:10.1111/jch.70166

BibTeX
@article{Hua2025,
  author = {Hua, Yang and Li, Meng-Huan and Wu, Ting-Ting and Jing, Lei and Jiang, Ming and Liu, Cui-Ying and Yang, Jia-Ming and Lou, Yu-Xuan and Yuan, Yue and Tian, Yun-Fan and Zhang, Min and Wang, Rong-Sheng and Cai, Jing and Sheng, Yan-Hui and Sun, Wei and Kong, Xiang-Qing},
  title = {Focused Power Ultrasound Mediated Inferior Perirenal Adipose Tissue Modification Therapy for Essential Hypertension: A Pilot Study},
  journal = {The Journal of Clinical Hypertension},
  year = {2025},
  doi = {10.1111/jch.70166}
}
Kostenlos starten →